Effect of phenoxybenzamine (dibenzyline) on sexual function in man.
Phenoxybenzamine (Dibenzyline) has been extremely effective in treating patients with detrusor dyssynergia. Its minimal side effects include: mouth dryness, nasal congestion, drowsiness and fatigue, nausea and vomiting, palpitations, ejaculatory failure, and retrograde ejaculation. Nineteen men treated with phenoxybenzamine for detrusor dyssynergia reported ejaculatory failure during treatment; normal ejaculation returned after treatment was discontinued. Postmasturbation urine and semen samples were analyzed for sperm and fructose. The results of the study suggest that ejaculatory failure was due to the lack of seminal emission into the posterior urethra, rather than retrograde ejaculation. Some implications of this study are also discussed.
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects; D000328:Adult; D004542:Ejaculation / Q000187:drug effects*; D006801:Humans; D008297:Male; D010643:Phenoxybenzamine / Q000009:adverse effects* / Q000627:therapeutic use; D012669:Seminal Vesicles / Q000187:drug effects; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy
D000317:Adrenergic alpha-Antagonists; D010643:Phenoxybenzamine